2,3,7,8-Tetrabroomdibenzo-p-dioxine-13C12
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
2,3,7,8-Tetrabromo dibenzo-p-dioxin-13C12 is 13C labeled 2,3,7,8-Tetrabromodibenzo[b, E][1,4]dioxine[1].
125749-35-1
12352005
Isotope-Labeled Compounds
Others
Others
Br[13C]1=[13C](Br)[13CH]=[13C]2[13C](O[13C]3=[13CH][13C](Br)=[13C](Br)[13CH]=[13C]3O2)=[13CH]1
13C12H4Br4O2
511.69
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.
Room temperature
http://file.medchemexpress.com/batch_PDF/HY-W715121S/
Isotope-Labeled Compounds
No Development Reported
Beschrijving
2,3,7,8-Tetrabromo dibenzo-p-dioxin-13C12 is 13C labeled 2,3,7,8-Tetrabromodibenzo[b, E][1,4]dioxine[1].
Specificaties
Recent bekeken producten
ExactaCruz® Pipette Tip Reload System, 50-1250 μl, case
sc-201714
80 Racks/Case
Disc Membrane Hydrophobic PTFE, 0.22μm
CPTB14222
50 PCS
Rat Serum Albumin
CSB-NP000101r-01
1 mg
Denhardt's Solution (50X)
EC-915
50 mL
FKBP4, ID (FK506-binding Protein 4, Peptidyl-prolyl cis-trans Isomerase FKBP4, PPIase FKBP4, Rotamase, HSP-binding Immunophilin, HBI, FKBP52 Protein, 52kD FK506-binding Protein, 52kD FKBP, FKBP-52, 59kD Immunophilin, FKBP59, p59 Protein, FKBP-4, FKBP52)
MBS623609-01
0.2 mL
West Nile Virus, NS3 Protease (WNV)
MBS603723-01
0.1 mg
Human Sertoli Cell Complete Medium
MBS2576755-01
100 mL
Urobilinogen protein
MBS5303823-01
100 mg
Recent gezochte producten
ExactaCruz® Pipette Tip Reload System, 50-1250 μl, case
sc-201714
80 Racks/Case
Cbp 3'UTR Luciferase Stable Cell Line
TU201714
1.0 mL
Mouse Gpx2 activation kit by CRISPRa
GA201714
1 Kit
CCDC50 Human qPCR Template Standard (NM_174908)
HK201714
1 Kit
Prpsap2 Mouse qPCR Template Standard (NM_144806)
MK201714
1 Kit
Horse Prekallikrein Affinity Purified
B2017141
50 µg
Human Recombinant Activin A
B2017149
10 µg
Mouse Alpha-N-acetyl-neuraminyl-2, 3-beta-galactosyl-1, 3-N-acetyl-galactosaminide alpha-2, 6-sialyltransferase (ST6GALNAC4) ELISA Kit
MBS7201714-01
48 Well